Details for New Drug Application (NDA): 091322
✉ Email this page to a colleague
The generic ingredient in MEFENAMIC ACID is mefenamic acid. There are thirteen drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the mefenamic acid profile page.
Summary for 091322
Tradename: | MEFENAMIC ACID |
Applicant: | Lupin Ltd |
Ingredient: | mefenamic acid |
Patents: | 0 |
Pharmacology for NDA: 091322
Mechanism of Action | Cyclooxygenase Inhibitors |
Medical Subject Heading (MeSH) Categories for 091322
Suppliers and Packaging for NDA: 091322
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
MEFENAMIC ACID | mefenamic acid | CAPSULE;ORAL | 091322 | ANDA | Lupin Pharmaceuticals, Inc. | 68180-185 | 68180-185-06 | 30 CAPSULE in 1 BOTTLE (68180-185-06) |
MEFENAMIC ACID | mefenamic acid | CAPSULE;ORAL | 091322 | ANDA | Advanced Rx of Tennessee, LLC | 80425-0423 | 80425-0423-1 | 30 CAPSULE in 1 BOTTLE (80425-0423-1) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 250MG | ||||
Approval Date: | Jul 22, 2011 | TE: | AB | RLD: | No |
Complete Access Available with Subscription